Safety and efficacy of metformin in a restricted formulary

American Journal of Managed Care

Volumn 5, Issue 1, 1999, Pages 62-68

  Swislocki, Arthur L M ^a,b   Khuu, Quan ^a   Liao, Ellen ^a   Wu, Emily ^a   Beza, Fil ^a   Lopez, Julio ^a   Kwan, Gene ^a   Noth, Robert H ^a,b  

^a VA NORTHERN CALIFORNIA HEALTH CARE SYSTEM   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIGUANIDE DERIVATIVE; HEMOGLOBIN A1C; INSULIN; METFORMIN; ORAL ANTIDIABETIC AGENT; SULFONYLUREA DERIVATIVE;

ADULT; AGED; ARTICLE; DIABETES CONTROL; DIABETES MELLITUS; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG SAFETY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0032918959     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Davidson MB, Peters AL. An overview of metformin in the treatment of type 2 diabetes mellitus. Am J Med 1997; 102:99-110.
2. DeFronzo RA, Goodman AM. Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group. N Engl J Med 1995;333:541-549.
3. Sirtori CR, Pasik CR. Re-evaluation of a biguanide, metformin: Mechanism of action and tolerability. Pharmacol Res 1994;30:187-228.
4. Bailey CJ, Turner RC. Metformin. N Engl J Med 1996;334:574-579.
5. Turner R, Cull C, Holman R. United Kingdom Prospective Diabetes Study 17: A 9-year update of a randomized, controlled trial on the effect of improved metabolic control on complications in non-insulin-dependent diabetes mellitus. Ann Intern Med 1996;124:136-145.
6. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-986.
7. 1C temporally associated with improved process of care in VA Northern California Health Care System (VANCHCS) [abstract]. J Invest Med 1997;45:100A.
8. American Diabetes Association. American Diabetes Association: Clinical Practice Recommendations 1997. Diabetes Care 1997;20(suppl 1).
9. Shott S. Statistics for Health Professionals. Philadelphia, PA: WB Saunders; 1990.
10. Kaplan MH, Feinstein AR. The importance of classifying initial co-morbidity in evaluating the outcome of diabetes mellitus. J Chron Dis 1974;27:387-404.
11. Ahroni JH, Boyko EJ, Davignon DR, Pecoraro RE. The health and functional status of veterans with diabetes. Diabetes Care 1994;17:318-321.
12. Ferrannini E, Stern MP, Galvan AQ, Mitchell BD, Haffner SM. Impact of associated conditions on glycemic control of NIDDM patients. Diabetes Care 1992;15: 508-514.
13. Carlsen SM, Rossvoll O, Bjerve KS, Folling I. Metformin improves blood lipid pattern in nondiabetic patients with coronary heart disease. J Int Med 1996;239:227-233.
14. Fanghanel G, Sanchez-Reyes L, Trujillo C, Sotres D, Espinosa-Campos J. Metformin's effects on glucose and lipid metabolism in patients with secondary failure to sulfonylureas. Diabetes Care 1996;19:1185-1189.
15. Giugliano D, Quatraro A, Consoli G, et al. Metformin for obese, insulin-treated diabetic patients: Improvement in glycaemic control and reduction of metabolic risk factors. Eur J Clin Pharm 1993;44:107-112.
16. Grant PJ. The effects of high- and medium-dose metformin therapy on cardiovascular risk factors in patients with type II diabetes. Diabetes Care 1996;19:64-66.
17. Giugliano D, De Rosa N, Di Maro G, et al. Metformin improves glucose, lipid metabolism, and reduces blood pressure in hypertensive, obese women. Diabetes Care 1993;16:1387-1390.
18. Jeppesen J, Zhou MY, Chen YD, Reaven GM. Effect of metformin on postprandial lipemia in patients with fairly to poorly controlled NIDDM. Diabetes Care 1994;17: 1093-1099.
19. Landin K, Tengborn L, Smith U. Treating insulin resistance in hypertension with metformin reduces both blood pressure and metabolic risk factors. J Int Med 1991; 229:181-187.
20. Bhalla RC, Toth KF, Tan E, Bhatty RA, Mathias E, Sharma RV. Vascular effects of metformin: Possible mechanisms for its antihypertensive action in the spontaneously hypertensive rat. Am J Hypertension 1996;9:570-576.
21. Sambol NC, Chiang J, O'Conner M, et al. Pharmacokinetics and pharmacodynamics of metformin in healthy subjects and patients with noninsulin-dependent diabetes mellitus. J Clin Pharmacol 1996;36:1012-1021.